|
CN111686247A
|
|
Liquid composition comprising antibodies to human interleukin-4 receptor alpha
|
|
WO2019210511A1
|
|
Addition salt of s1p1 receptor agonist and crystal form thereof, and pharmaceutical composition
|
|
CN108299412A
|
|
The addition salts and its crystal form and pharmaceutical composition of a kind of S1P1 receptor stimulating agents
|
|
CN107474134A
|
|
Antibody for the acceptor of bind interleukin 4
|
|
CN105348276A
|
|
Synthetic method for 1-{2-floro-4-[5-(4-isobutyl phenyl)-1,2,4-oxadiazol-3-yl]-benzyl}-3-azetidinecarboxylic acid
|
|
CN105315266A
|
|
Crystal forms of 1-{2-fluoro-4-[5-(4-isobutyl phenyl)-1,2,4-oxadiazole-3-yl]-benzyl}-3-azetidinecarboxylic acid
|
|
CN103450171A
|
|
Novel immune adjustment compound, application thereof and medicine combination comprising same
|
